TGFB1 and neoplasm: Hence, targeting TGF-β and pro-tumor TAMs as a therapeutic strategy for PDAC requires a more complete understanding of their roles in PDAC, especially in the TGF-β interaction with TAM sub-populations in the PDAC tumor.